Design, Development and Standardization of a Unique Herbal Formulation for the Treatment of Migraine

Migraine is a chronic neurological disorder associated with significant disability and reduced quality of life. Limitations and adverse effects of conventional pharmacotherapy have increased interest in complementary and integrative approaches. Herbal medicines, grounded in traditional systems, offer multi-target therapeutic potential with improved tolerability. A randomised controlled clinical study was conducted involving 60 migraine patients without aura. Participants were allocated to a Herbal Medicine group (HM, n=30) receiving Panchakarma (virechana) followed by a standardized polyherbal formulation for 90 days, and a Control group (CT, n=30) receiving standard symptomatic treatment with NSAIDs. Outcomes were assessed using the Cerebral Headache Questionnaire (CHQQ), Visual Analogue Scale (VAS), Migraine Disability Assessment Scale (MIDAS), Perceived Stress Scale (PSS), heart rate variability (HRV), and surface electromyography (sEMG) of the frontalis muscle. Phytochemical standardisation and antioxidant studies were also performed. Statistical analysis was conducted using repeated-measures ANOVA with Bonferroni post-hoc testing.

Migraine, Polyhedral formulation, Panchakarma

1. Ahn AH, Basbaum AI. Where do triptans act in the treatment of migraine? Pain. 2005;115(1):1-4. [Google Scholar] [Crossref]

2. Albrecht C, Thormann W. Determination of naproxen in liver and kidney tissues by electrokinetic capillary chromatography with laser-induced fluorescence detection. Journal of Chromatography A. 1998;802(1):115-20. [Google Scholar] [Crossref]

3. Ophoff RA, van den Maagdenberg AM, Roon KI, Ferrari MD, Frants RR. The impact of pharmacogenetics on migraine. European journal of pharmacology. 2001;413(1):1-10. [Google Scholar] [Crossref]

4. Andrew PD, Birch HL, Phillpot DA. Determination of sumatriptan succinate in plasma and urine by high-performance liquid chromatography with electrochemical detection. Journal of Pharmaceutical Sciences. 1993;82(1):73-6. [Google Scholar] [Crossref]

5. Arulmozhi D, Veeranjaneyulu A, Bodhankar S. Migraine: current concepts and emerging therapies. Vascular pharmacology. 2005;43(3):176-87. [Google Scholar] [Crossref]

6. Bisht K, Kotwal S, Vidyarthi V, Singh DS, Pahwa P. An Ayurvedic approach in the management of Migraine: A Review Study. Journal of Ayurveda and Integrated Medical Sciences. 2019;4(04):241-6. [Google Scholar] [Crossref]

7. Boulton DW, Duncan GF, Vachharajani NN. Validation and application of a high‐performance liquid chromatography/tandem mass spectrometry assay for sumatriptan in human plasma. Biomedical Chromatography. 2003;17(1):48-52. [Google Scholar] [Crossref]

8. BROWN RP, GERBARG PL. Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity. Journal of Psychiatric Practice®. 2001;7(2):75-91. [Google Scholar] [Crossref]

9. De Vries P, Sánchez-López A, Centurión D, Heiligers JP, Saxena PR, Villalón CM. The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists. European journal of pharmacology. 1998;362(1):69-72. [Google Scholar] [Crossref]

10. Farré M, Petrovic M, Gros M, Kosjek T, Martinez E, Heath E, et al. First interlaboratory exercise on non-steroidal anti-inflammatory drugs analysis in environmental samples. Talanta. 2008;76(3):580-90. [Google Scholar] [Crossref]

11. Čakrt M, Hercegová A, Leško J, Polonský J, Sádecká J, Skačáni I. Isotachophoretic determination of naproxen in the presence of its metabolite in human serum. Journal of Chromatography A. 2001;916(1-2):207-14. [Google Scholar] [Crossref]

12. Gallo P, Fabbrocino S, Vinci F, Fiori M, Danese V, Nasi A, et al. Multi-residue determination of non-steroidal anti-inflammatory drug residues in animal serum and plasma by HPLC and photo-diode array detection. Journal of chromatographic science. 2006;44(10):585-90. [Google Scholar] [Crossref]

13. Chen Y, Wang S, Wang Y. Role of herbal medicine for prevention and treatment of migraine. Phytotherapy Research. 2022;36(2):730-60. [Google Scholar] [Crossref]

14. Cruz-Vera M, Lucena R, Cárdenas S, Valcárcel M. Ionic liquid-based dynamic liquid-phase microextraction: Application to the determination of anti-inflammatory drugs in urine samples. Journal of Chromatography A. 2008;1202(1):1-7. [Google Scholar] [Crossref]

15. MacGregor E, Brandes J, Eikermann A, Giammarco R. Impact of migraine on patients and their families: the Migraine and Zolmitriptan Evaluation (MAZE) survey–Phase III. Current medical research and opinion. 2004;20(7):1143-50. [Google Scholar] [Crossref]

16. Niazi M, Hashempur MH, Taghizadeh M, Heydari M, Shariat A. Efficacy of topical Rose (Rosa damascena Mill.) oil for migraine headache: A randomized double-blinded placebo-controlled cross-over trial. Complementary therapies in medicine. 2017;34:35-41. [Google Scholar] [Crossref]

17. Cueva‐Mestanza R, Torres‐Padrón M, Sosa‐Ferrera Z, Santana‐Rodríguez J. Microwave‐assisted micellar extraction coupled with solid‐phase extraction for preconcentration of pharmaceuticals in molluscs prior to determination by HPLC. Biomedical Chromatography. 2008;22(10):1115-22. [Google Scholar] [Crossref]

• QbD Approach to Hplc Method Development and Validation of the Simultaneous Estimation of Sulbactum and Durlobactum in Pharmaceutical Dosage Form
• A Review on an Evaluation of a Liposomal Hydrogel for Combined Minoxidil and Tretinoin Delivery in Androgenetic Alopecia
• Qualitative Screening and Analysis of Lunasia amara Blanco (Tawal-ulad) Ethanolic Leaves Extract as Potential Anti-Angiogenic Inhibitors Using the Chorioallantoic Membrane Assay on Mallard Duck Embryo
• A Comprehensive Review on Calotropis Procera on Its Analgesic Activity
• Formulation, Characterization and In-Vitro Evaluation of Curcumin Loaded Liposome for Colon Drug delivery